Lin BioScience (6696.TWO) Earnings Analysis
Lin BioScience (6696.TWO) next reports earnings on 2026-08-12. Trailing P/E -45.33.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6696.TWO next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
6696.TWO earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
6696.TWO valuation and analyst view
| Trailing P/E | -45.33 |
|---|---|
| Trailing EPS | -16.72804 TWD |
| Price / book | 5.75 |
| Dividend yield | 0.00% |
| Market cap | 56.88B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Lin BioScience (6696.TWO)'s next earnings date?
Lin BioScience is next scheduled to report on 2026-08-12.
What is 6696.TWO's current P/E ratio and EPS?
6696.TWO trades at a trailing P/E of -45.33 on trailing EPS of -16.728038197640878 TWD.
What do analysts rate 6696.TWO?
6696.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.